Journals / Klinik Psikofarmakoloji Bülteni / 2012 / Cilt: 22 - Sayı: 1

Varenicline Induced Psychosis

Pages
110–111
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

GÜLER, Ö., ANNAGÜR, B. B., TEKİNARSLAN, E. (2022). Varenicline Induced Psychosis. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 1, 110–111. https://ajindex.com/articles/574127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Cahill K, Stead L, Lancaster T. A preliminary benefit-risk assessment of varenicline in smoking cessation. Drug Saf 2009;32(2):119-35
  2. Hays JT, Ebert JO. Varenicline for tobacco dependence. N Engl J Med 2008;359(19):2018-24
  3. Freedman R. Exacerbation of schizophrenia by varenicline. Am J Psychiatry 2007;64(8):1269
  4. Food and Drug Administration. FDA Med Watch Alert, Varenicline (marketed as Chantix): Information, February 1, 2008, and November 20, 2007. Available at www.fda.gov/cder/drug/infopage/ varenicline/default.htm
  5. Kuehn BM. Varenicline gets stronger warnings about psychiatric problems, vehicle crashes. JAMA 2009;302(8):834
  6. DiPaula BA, Thomas MD. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. Pharmacotherapy 2009;29(7):852-7
  7. Pumariega AJ, Nelson R, Rotenberg L. Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr 2008;13(6):511-4
  8. Xi ZX. Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients. Drug Health Patient Saf 2010;(2):39-48.